Share
deficiencies in the oversight of the 340b drug pricing program
Us Department of Health and Human Servic
(Author)
·
Daniel R. Levinson
(Author)
·
Office of Inspector General (Oig)
(Author)
·
Bibliogov
· Paperback
deficiencies in the oversight of the 340b drug pricing program - Levinson, Daniel R. ; Office of Inspector General (Oig) ; Us Department of Health and Human Servic
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: U.S.A.
(Import costs included in the price)
It will be shipped from our warehouse between
Thursday, July 18 and
Thursday, July 25.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "deficiencies in the oversight of the 340b drug pricing program"
The Office of the Inspector General (OIG) is an office that is part of the Cabinet departments and independent agencies of the United States federal government as well as some state and local governments. Each office includes an Inspector General and employees charged with identifying, auditing, and investigating, fraud, waste, abuse, and mismanagement within the parent agency. The Office of Evaluation and Inspections (OEI) conducts management and program evaluations that focus on issues of concern to HHS, the Congress and the public. OEI publishes reports, studies, research and books to better inform the people. Some of these documents include titles like: Dietary Supplement Labels: Key Elements, Electronic Media Claims and Contractors' For-Profit Subsidiaries, and Child Support and the Military. This document is an OEI publication.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
